Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Chatbot rosie aims to cut postpartum depression in minority moms

NCT ID NCT06053515

First seen May 12, 2026 · Last updated Jun 23, 2026 · Updated 8 times

Summary

This study tested a free chatbot called Rosie that gives pregnant women and new moms instant, reliable health information from trusted sources. 400 minority women who were pregnant or had an infant under 6 months used the chatbot to ask questions and get answers. The goal was to see if this tool could reduce postpartum depression, emergency room visits, and improve attendance at well-baby checkups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Maryland

    College Park, Maryland, 20742, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Rosie the Chatbot (educational chatbot)

What this could lead to

If it works, this could point toward a simple, free tool to help new moms get reliable health answers and potentially reduce postpartum depression and unnecessary ER visits.

What could go wrong

This is a completed study with 400 participants, but results are not yet published. The chatbot provides information only, not medical care, so it may not change health outcomes on its own.

Conditions

The condition(s) this trial relates to.

postpartum depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.